Centre François baclesse
Caen, 14000, France
NCT Number: NCT04554927
The investigators hypothesize that the implementation of a Web-application in patients initiating adjuvant hormone therapy for breast cancer brings a benefit on treatment adherence and quality of life.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
Female
Interventional
Not applicable
Caen, 14000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patients of the Web-application arm will be trained on the devices and the application will be installed either on their smartphone or on another support (computer, tablet).
Personalized schedule of medical follow-up given to the patient
Time frame: 18 months
Evaluate the benefit of a web-based application on hormone therapy compliance (Morisky questionnary; answer Yes or No; 8 questions)
Time frame: 18 months
Quality of life scores according (EORTC QLQ-C30 self-questionnaires ; minimum not at all to maximum Lot; 30 questions)
Time frame: 18 months
uality of life scores according (EORTC QLQ-BR23 self-questionnaires ; minimum not at all to maximum Lot; 23 questions)
Centre Francois Baclesse
Other
Acronym: WEBAPPAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05715255
Breast Cancer, Breast Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05896189
Breast Cancer, Breast Diseases
Anchorage, Alaska, United States
View Trial DetailsNCT02942355
Breast Cancer, Breast Diseases
Charlotte, North Carolina, United States
View Trial DetailsNCT04461808
Breast Cancer, Breast Diseases
Reggio Emilia, Italy
View Trial Details